N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery

Critical Care Medicine

Volumn 36, Issue 5, 2008, Pages 1427-1435

  Barr, Linda F ^a   Kolodner, Kenneth ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Pulmonary and Critical Care Associates of Baltimore   (United States)

Author keywords

Acute renal failure; Cardiac surgery; Chronic renal insufficiency; Fenoldopam; Length of stay; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; APROTININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENOLDOPAM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMMUNITY HOSPITAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG COST; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG WITHDRAWAL; FEMALE; HEART SURGERY; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE; INTRAOPERATIVE PERIOD; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 42949133370     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31816f48ba     Document Type: Article

References (68)

1. JK Hix CV Thakar EM Katz Effect of off-pump coronary artery bypass graft surgery on postoperative acute kidney injury and mortality Crit Care Med 34 2006 2979 2983
2. GJ Mangos MA Brown WY Chan Acute renal failure following cardiac surgery: Incidence, outcomes and risk factors Aust NZ J Med 25 1995 284 289
3. GM Chertow JM Lazarus CL Christiansen Preoperative renal risk stratification Circulation 95 1997 878 884
4. T Llopart R Lombardi M Forselledo Acute renal failure in open heart surgery Ren Fail 19 1997 319 323
5. CM Mangano LS Diamondstone JG Ransay Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group Ann Intern Med 128 1998 194 203
6. OV Hein J Birnbaum KD Wernecke Three-year survival after four major post-cardiac operative complications Crit Care Med 34 2006 2729 2737
7. E Nozawa E Azeka AM Ignez Factors associated with failure of weaning from long-term mechanical ventilation after cardiac surgery Int Heart J 46 2005 819 831
8. MG Massad J Kpodonu J Lee Outcome of coronary artery bypass operations in patients with renal insufficiency with and without renal transplantation Chest 128 2005 855 862
9. DT Wong DC Cheng R Tibshirani Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing coronary artery bypass graft with fast-track cardiac anesthesia: A new cardiac risk score Anesthesiology 91 1999 936 944
10. G Asimakopoulos AP Karagounis O Valencia Renal function after cardiac surgery off- versus on-pump coronary artery bypass: Analysis using the Cockcroft-Gault formula for estimating creatinine clearance Ann Thorac Surg 79 2005 2024 2031
11. T Bardell JF Legare KJ Buth ICU readmission after cardiac surgery Eur J Cardiothorac Surg 23 2003 354 359
12. W Pan P Tatjana J Anton Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery Circulation 110 Suppl II 2004 II45 II49
13. MJ Holzmann S Ahnve N Hammar Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting J Thorac Cardiovasc Surg 130 2005 746 752
14. A Kuitunen A Vento R Suojaranta-Ylinen Acute renal failure after cardiac surgery: Evaluation of the RIFLE classification Ann Thorac Surg 81 2006 54254 54256
15. I Bahar A Akgul MA Ozatik Acute renal failure following open heart surgery: Risk factors and prognosis Perfusion 20 2005 317 322
16. EH Kincaid DA Ashburn JR Hoyle Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery Ann Thorac Surg 80 2005 1388 1393
17. M Hilberman GC Derby RJ Spencer Sequential pathophysiological changes characterizing the progression from renal dysfunction to acute renal failure following cardiac operation J Thorac Cardiovasc Surg 79 1980 838 844
18. V Mazzarella MT Gallucci C Toxxo Renal function in patients undergoing cardiopulmonary bypass operations J Thorac Cardiovasc Surg 104 1992 1625 1627
19. P Colson J Ribstein A Mimran Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery Anesthesiology 72 1990 23 27
20. P Tossios W Bloch A Huebner N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in cardiac surgery patients: Results of a randomized double-blinded placebo-controlled clinical trial J Thorac Cardiovasc Surg 126 2003 1513 1520
21. LW Andersen J Thiis A Kharazmi The role of N-acetylcysteine administration on the oxidative response of neutrophils during cardiopulmonary bypass Perfusion 10 1995 21 26
22. GM Sreeram HP Grocott WD White Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 18 2004 548 551
23. M Halpenny S Lakshmi A O’Donnell Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting Anaesthesia 56 2001 953 960
24. R Ascione CT Lloyd MJ Underwood On-pump versus off-pump coronary revascularization: Evaluation of renal function Ann Thorac Surg 68 1999 493 498
25. A Chukwuemeka A Weisel M Maganti Renal dysfunction in high-risk patients after on-pump and off-pump coronary artery bypass surgery: A propensity score analysis Ann Thorac Surg 80 2005 2148 2153
26. NM Schwann JC Horrow MD Strong III Does off-pump coronary artery bypass reduce the incidence of clinically evident renal dysfunction after multivessel myocardial revascularization? Anesth Analg 99 2004 959 964
27. J Bucerius JF Gummert T Walther On-pump versus off-pump coronary artery bypass grafting: Impact on postoperative renal failure requiring renal replacement therapy Ann Thorac Surg 77 2004 1250 1256
28. MI Stallwood AD Grayson K Mills Acute renal failure in coronary artery bypass surgery: Independent effect of cardiopulmonary bypass Ann Thorac Surg 77 2004 968 972
29. JO Friedrich N Adhikari MS Herridge Meta-analysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death Ann Intern Med 142 2005 510 524
30. PJ Kulka M Tryba M Zenz Preoperative alpha2 adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: Results of a randomized, controlled trial Crit Care Med 24 1996 947 952
31. AT Tang C Alexiou J Hsu Leukodepletion reduces renal injury in coronary revascularization: A prospective randomized study Ann Thorac Surg 74 2002 372 377
32. F Ryckwaert P Colson J Ribstein Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction Br J Anaesth 86 2001 169 175
33. AM Morariu BG Loef LPHJ Aarts Dexamethasone: Benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: A study on myocardial, pulmonary, renal, intestinal, and hepatic injury Chest 128 2005 2677 2687
34. K Sward F Valsson P Odencrants Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo controlled trial Crit Care Med 32 2004 1310 1315
35. M Tepel M van der Giet C Schwarzfeld Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
36. CSR Baker A Wragg S Kumar A rapid protocol for the prevention of contrast-induced renal dysfunction: The RAPPID Study J Am Coll Cardiol 41 2003 2114 2118
37. RM Carey HM Siragy NV Ragsdale Dopamine-1 and dopamine-2 mechanisms in the control of renal function Am J Hypertens 3 1990 59S 63S
38. UM Fischer P Tossios U Mehlhorn Renal protection by radical scavenging in cardiac surgery patients Curr Med Res Opin 21 2005 1161 1164
39. A Ristikankare T Kuitunen A Kuitunen Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery Br J Anaesth 97 2006 611 616
40. KWA Burns MWA Chu RJ Novick Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: A randomized controlled trial JAMA 294 2005 342 350
41. M Haase An Haase-Fielitz SM Bagshaw Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients Crit Care Med 35 2007 1324 1331
42. M Ranucci G Soro N Barzaghi Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients Ann Thorac Surg 78 2004 1332 1338
43. S Garwood CP Swamidoss EA Davis A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction J Cardiothorac Vasc Anesth 17 2003 17 21
44. T Bove L Giovanni MG Calabro Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: A prospective, double-blind, randomized clinical trial Circulation 111 2005 3230 3235
45. P-P Caimmi L Pagani E Micalizzi Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass J Cardiothorac Vasc Anesth 17 2003 491 494
46. JA Tumlin A Wang PT Murray Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: A pilot trial in the prevention of contrast nephropathy Am Heart J 143 2002 894 903
47. VS Mathur SK Swan LJ Lambrecht The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects Crit Care Med 27 1999 1832 1837
48. MB Murphy CE McCoy RR Weber Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine 1 agonist fenoldopam Circulation 6 1987 1312 1318
49. AA Taylor AM Shepherd W Polvino Prolonged fenoldopam infusions in patients with mild to moderate hypertension: Pharmacodynamic and pharmacokinetic effects Am J Hypertens 12 1999 906 914
50. DW Hunter A Chamsuddin H Bjamason Preventing contrast-induced nephropathy with fenoldopam Tech Vasc Interv Radiol 4 2001 53 56
51. H Izzedine V Guerin V Launay-Vacher Effect of N-acetylcysteine on serum creatinine level Nephrol Dial Transplant 16 2001 1514 1515
52. DW Cockcroft MH Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 36
53. L Noyez I Plesiewicz FW Verheugt Estimated creatinine clearance instead of plasma creatinine level as prognostic test for postoperative renal function in patients undergoing coronary artery bypass surgery Eur J Cardiothorac Surg 29 2006 461 465
54. F Wang JY Dupuis H Nathan An analysis of the association between preoperative renal dysfunction and outcome in cardiac surgery: Estimated creatinine clearance or plasma creatinine as measures of renal function Chest 124 2003 1842 1862
55. DN Wijeysundera V Rao WS Beattie Evaluating surrogate measures of renal dysfunction after cardiac surgery Anaesth Analg 96 2003 1265 1273
56. DN Wijeysundera K Karkouti WS Beattie Improving the identification of patients at risk of postoperative renal failure after cardiac surgery Anesthesiology 104 2006 65 72
57. WS Suen CK Mok SW Chiu Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery Angiology 49 1998 789 800
58. M-L Cittanova A Zubicki C Savu The chronic inhibition of angiotensin-converting enzyme impairs postoperative renal function Anesth Analg 93 2001 1111 1115
59. EH Kincaid DA Ashburn JR Hoyle Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg 80 2005 1388 1393
60. LL Clark JS Ikonomidis FA Crawford Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: An 8-year retrospective cohort study J Thorac Cardiovasc Surg 131 2006 679 685
61. DT Mangano IC Tudor C Dietzel Multicenter Study of Perioperative Ischemia Research Group Ischemia Research and Education Foundation: The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353 365
62. E Maris Covariance adjustment versus gain scores—revisited Psychol Meth 3 1998 309 327
63. S Cuzzocrea E Mazzon G Costantino Effects of N-acetylcysteine in a rat model of ischemia and reperfusion injury Cardiovasc Res 47 2000 537 548
64. X Zhou A Zhao G Goping Gliotoxin-induced cytotoxicity proceeds via apoptosis and is mediated by caspases and reactive oxygen species in LLC-PK1 cells Toxicol Sci 54 2000 194 202
65. MG Salom P Ramirez LF Carbonell Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior vena cava occlusion Transplantation 65 1998 1315 1321
66. SN Heyman M Goldfarb A Shina N-acetylcysteine ameliorates renal microcirculation in rats Kidney Int 63 2003 634 641
67. H Girouard C Chulak L Wu N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats Am J Hypertens 16 2003 577 584
68. GW Stone PA McCullough JA Tumlin Fenoldopam mesylate for the prevention of contrast-induced nephropathy: A randomized controlled trial JAMA 290 2003 2284 2291